Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SyncoZymes is a high-tech biotechnology company specializing in the development and application of green chemistry solutions for the pharmaceutical industry. The company leverages a proprietary biocatalysis platform to design and evolve enzymes for the efficient synthesis of active pharmaceutical ingredients (APIs) and high-value intermediates. Their core offerings include enzyme screening, directed evolution, and large-scale GMP manufacturing of products such as NMN, NAD, and various chiral chemicals. By replacing traditional chemical catalysts with biological ones, SyncoZymes enables more sustainable, cost-effective, and higher-purity production processes. Headquartered in Shanghai with significant manufacturing facilities in Zhejiang, the company serves a global client base across the life sciences and nutraceutical sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SyncoZymes.